Abstract
Evidence for Activity of GBR830 (Anti-OX40) in Extrinsic and Intrinsic Atopic Dermatitis (AD) in a Phase 2a Study
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have